Rebif Solution for Injection in Cartridge 22mcg0.5ml Singapore - English - HSA (Health Sciences Authority)

rebif solution for injection in cartridge 22mcg0.5ml

merck pte. ltd. - interferon beta-1a - injection, solution - 22mcg/0.5ml - interferon beta-1a 22mcg/0.5ml

Rebif Solution for Injection in Cartridge 44mcg0.5ml Singapore - English - HSA (Health Sciences Authority)

rebif solution for injection in cartridge 44mcg0.5ml

merck pte. ltd. - interferon beta-1a - injection, solution - 44mcg/0.5ml - interferon beta-1a 44mcg/0.5ml

AVONEX PEN Australia - English - Department of Health (Therapeutic Goods Administration)

avonex pen

biogen australia pty ltd - interferon beta-1a, quantity: 60 microgram/ml - injection, solution - excipient ingredients: polysorbate 20; glacial acetic acid; sodium acetate; water for injections; arginine hydrochloride - avonex is indicated for the treatment of patients with relapsing forms of multiple sclerosis (ms). avonex is indicated in patients who have experienced a single demyelinating event and are at risk of developing clinically definite ms based on the presence of brain mri abnormalities characteristic of ms. avonex 60 mcg is indicated for the treatment of secondary progressive ms in patients in whom relapse is still a feature of disease. avonex 60 mcg should not be initiated in patients with secondary progressive ms who have not experienced relapse in the previous 12 months.